Incyte (INCY) announces positive topline results from pivotal study of Tafasitamab as a first-line treatment for diffuse large B-cell lymphoma

Newsquawk StaffPublished On the live feed at 2 more headlines followed before this page went public
Newsquawk headlinesUTC

UK MHRA is reviewing license application for Novo Nordisk's (NOVOB DC) oral Semaglutide 25mg, expects to announce decision before year-end

US PRE-MARKET MOVERS: Mag-7, TSM, QXO, MBLY, HAL/CVX/XOM, DUOL

Incyte (INCY) announces positive topline results from pivotal study of Tafasitamab as a first-line treatment for diffuse large B-cell lymphoma

US BROKER MOVES: COIN upgraded at Goldman Sachs; ADBE downgraded at Jefferies

Mobileye (MBLY) announced it has secured a major US automaker as a customer ​for its next-generation chip, lifting production outlook, with ‌its self-driving technology rolled out as standard equipment in millions of vehicles

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.

Related headlines

The whole workspace, free to try.

Try it free